Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome

IMPORTANCE: Plasma phosphorylated tau217 (p-tau217), a biomarker of Alzheimer disease (AD), is of special interest in corticobasal syndrome (CBS) because autopsy studies have revealed AD is the driving neuropathology in up to 40% of cases. This differentiates CBS from other 4-repeat tauopathy (4RT)–...

Descripción completa

Detalles Bibliográficos
Autores principales: VandeVrede, Lawren, La Joie, Renaud, Thijssen, Elisabeth H., Asken, Breton M., Vento, Stephanie A., Tsuei, Torie, Baker, Suzanne L., Cobigo, Yann, Fonseca, Corrina, Heuer, Hilary W., Kramer, Joel H., Ljubenkov, Peter A., Rabinovici, Gil D., Rojas, Julio C., Rosen, Howie J., Staffaroni, Adam M., Boeve, Brad F., Dickerson, Brad C., Grossman, Murray, Huey, Edward D., Irwin, David J., Litvan, Irene, Pantelyat, Alexander Y., Tartaglia, Maria Carmela, Dage, Jeffrey L., Boxer, Adam L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071401/
https://www.ncbi.nlm.nih.gov/pubmed/37010841
http://dx.doi.org/10.1001/jamaneurol.2023.0488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071401/
https://www.ncbi.nlm.nih.gov/pubmed/37010841
http://dx.doi.org/10.1001/jamaneurol.2023.0488

Ejemplares similares